HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peng Wu Selected Research

trichostatin A (A 300)

1/2020The Antitumor Efficiency of Zinc Finger Nuclease Combined with Cisplatin and Trichostatin A in Cervical Cancer Cells.
1/2018Withdrawal Notice: Zinc Finger Nuclease Combines with Cisplatin and Trichostatin A Enhances the Antitumor Potency in Cervical Cancer Cells
6/2017Synergistic activity of the histone deacetylase inhibitor trichostatin A and the proteasome inhibitor PS-341 against taxane-resistant ovarian cancer cell lines.
1/2014Trichostatin A targets the mitochondrial respiratory chain, increasing mitochondrial reactive oxygen species production to trigger apoptosis in human breast cancer cells.
1/2013Ubiquitin B in cervical cancer: critical for the maintenance of cancer stem-like cell characters.
11/2009Identification of LIV1, a putative zinc transporter gene responsible for HDACi-induced apoptosis, using a functional gene screen approach.
2/2009[Construction of anti-sense cDNA library of human breast cancer cells during apoptosis induced by trichostatin A and preliminary screening of essential genes].
9/2005Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peng Wu Research Topics

Disease

133Neoplasms (Cancer)
12/2022 - 04/2002
29Inflammation (Inflammations)
10/2022 - 11/2014
28Infections
04/2022 - 04/2006
19Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2022 - 06/2005
19Neoplasm Metastasis (Metastasis)
01/2022 - 11/2010
16COVID-19
07/2022 - 01/2020
15Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 04/2007
14Breast Neoplasms (Breast Cancer)
01/2022 - 02/2009
14Carcinogenesis
01/2022 - 09/2006
12Photosensitivity Disorders (Photodermatitis)
08/2022 - 01/2017
10Myocardial Infarction
02/2023 - 01/2015
10Carcinoma (Carcinomatosis)
01/2021 - 09/2006
9Pain (Aches)
10/2022 - 07/2012
9Hemorrhage
06/2022 - 03/2016
9Fibrosis (Cirrhosis)
01/2022 - 05/2013
9Prostatic Neoplasms (Prostate Cancer)
01/2021 - 12/2012
9Human Influenza (Influenza)
01/2020 - 03/2010
8Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 08/2015
7Wounds and Injuries (Trauma)
01/2022 - 10/2015
7Hypoxia (Hypoxemia)
01/2022 - 01/2015
7Stomach Neoplasms (Stomach Cancer)
01/2021 - 04/2015
7Nasopharyngeal Carcinoma
01/2020 - 05/2013
6Necrosis
06/2022 - 11/2014
6Knee Osteoarthritis
01/2022 - 01/2020
6Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2021 - 01/2018
6Type 2 Diabetes Mellitus (MODY)
11/2021 - 10/2016
6Reperfusion Injury
01/2021 - 01/2015
6Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 04/2012
6Renal Cell Carcinoma (Grawitz Tumor)
11/2017 - 03/2005
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 09/2016
5Hypertension (High Blood Pressure)
01/2021 - 11/2016
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2018 - 03/2009
4Sarcopenia
12/2022 - 09/2018
4Thrombosis (Thrombus)
10/2022 - 11/2019
4Alzheimer Disease (Alzheimer's Disease)
01/2022 - 08/2010
4Edema (Dropsy)
01/2022 - 11/2015
4Hepatolenticular Degeneration (Wilson's Disease)
01/2022 - 05/2019
4Virus Diseases (Viral Diseases)
01/2022 - 01/2015
4Obesity
12/2021 - 08/2019
4Body Weight (Weight, Body)
12/2021 - 04/2015
4Dehydration (Water Stress)
08/2021 - 03/2012
4Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2021 - 07/2016
4Stroke (Strokes)
01/2021 - 02/2018
4Lymphatic Metastasis
01/2021 - 03/2008
4Lung Neoplasms (Lung Cancer)
12/2020 - 03/2012
4Atherosclerosis
10/2020 - 02/2009

Drug/Important Bio-Agent (IBA)

54Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2005
33Biomarkers (Surrogate Marker)IBA
12/2022 - 06/2005
25Biological ProductsIBA
04/2022 - 04/2008
24Pharmaceutical PreparationsIBA
04/2022 - 08/2002
18CytokinesIBA
01/2022 - 01/2009
17Messenger RNA (mRNA)IBA
10/2022 - 06/2005
14DNA (Deoxyribonucleic Acid)IBA
01/2021 - 08/2002
13MicroRNAs (MicroRNA)IBA
01/2022 - 01/2014
11Therapeutic UsesIBA
02/2023 - 01/2014
11Cisplatin (Platino)FDA LinkGeneric
01/2022 - 05/2011
10RNA (Ribonucleic Acid)IBA
10/2022 - 12/2012
10VaccinesIBA
01/2022 - 08/2011
10EnzymesIBA
01/2022 - 09/2016
10Polysaccharides (Glycans)IBA
08/2021 - 05/2013
9LigandsIBA
12/2022 - 09/2005
9Interleukin-6 (Interleukin 6)IBA
01/2022 - 06/2017
9Long Noncoding RNAIBA
12/2021 - 09/2015
8Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 01/2014
8trichostatin A (A 300)IBA
01/2020 - 09/2005
8Histone Deacetylase InhibitorsIBA
01/2020 - 09/2005
7theasinensin AIBA
11/2020 - 09/2005
7KetamineFDA LinkGeneric
10/2020 - 08/2012
6Anti-Bacterial Agents (Antibiotics)IBA
03/2021 - 01/2017
6Small Interfering RNA (siRNA)IBA
11/2020 - 12/2012
6PlatinumIBA
01/2020 - 11/2013
5AlbuminsIBA
12/2022 - 06/2016
5Indicators and Reagents (Reagents)IBA
08/2022 - 04/2002
5MetalsIBA
01/2022 - 08/2010
5Phosphotransferases (Kinase)IBA
12/2020 - 04/2014
5Antiviral Agents (Antivirals)IBA
12/2020 - 01/2017
5Oxygen (Dioxygen)IBA
11/2020 - 03/2010
4Protein Isoforms (Isoforms)IBA
10/2022 - 01/2018
4Fluorescent Dyes (Fluorescent Probes)IBA
09/2022 - 01/2021
4Nucleic AcidsIBA
01/2022 - 06/2019
46-methyladenineIBA
01/2022 - 01/2021
4Circular RNAIBA
01/2022 - 01/2021
4CopperIBA
01/2022 - 05/2019
4NitrogenIBA
01/2022 - 02/2017
4LipidsIBA
12/2021 - 08/2019
4Blood Proteins (Serum Proteins)IBA
11/2021 - 05/2009
4Hemoglobins (Hemoglobin)IBA
03/2021 - 07/2019
4PowdersIBA
01/2021 - 07/2012
4AntigensIBA
01/2021 - 10/2017
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 01/2018
4CarbonIBA
03/2020 - 04/2015

Therapy/Procedure

50Therapeutics
02/2022 - 04/2002
15Drug Therapy (Chemotherapy)
01/2022 - 08/2002
7Length of Stay
01/2022 - 04/2015
7Extracorporeal Membrane Oxygenation
01/2021 - 03/2010
6Adjuvant Chemotherapy
11/2021 - 10/2012
5Immunotherapy
01/2022 - 10/2019
5Aftercare (After-Treatment)
01/2021 - 09/2016
4Ligation
01/2022 - 05/2013
4Debridement
09/2019 - 10/2015